Skip to main content

Table 1 Clinical data, BDI-II depression scores, imaging and histopathology data of the patients, who are listed in the order of decreasing BDI-II scores

From: Imaging cerebral tryptophan metabolism in brain tumor-associated depression

 

Gender

Age (years)

BDI-II score

New/rec

Tumor type

Grade

Area max (cm2)

Location

Side

1

F

55

33

New

Glioma

4

12.9

FP

R

2

F

22

30

New

Meningioma

2

8.5

F

R

3

M

52

28

New

Meningioma

1

12.2

Brainstem

M

4

M

67

22

New

Metastasis

 

1.8

F

R

5

M

70

20

New

Metastasis

 

17.7

TP

L

6

M

63

17

Rec

Glioma

2

43.6

FT

R

7

M

48

14

New

Glioma

3

25.3

F

L

8

F

49

13

New

Meningioma

1

9.6

F

L

9

M

59

11

New

Meningioma

1

4.6

Medulla

M

10

F

37

9

New

Glioma

2

11.8

F

L

11

M

58

8

Rec

Meningioma

2

8.7

P

R

12

M

25

6

New

Glioma

1

1

O

R

13

M

46

6

Rec

Glioma

4

2.6

PO, T

R

14

F

60

6

New

Metastasis

 

1.1

F

L

15

F

84

5

New

Meningioma

1

13.8

F

L

16

F

70

5

New

Glioma

4

1.6

T

R

17

M

60

3

New

Meningioma

1

13.2

Olfactory

M

18

F

62

3

New

Meningioma

 

6.2

FT

L

19

M

68

3

New

Meningioma

 

5.1

R lat clivus

R

20

M

79

2

New

Glioma

4

6.1

T

L

21

M

68

2

New

Meningioma

1

9.1

F

L

  1. BDI-II Beck Depression Inventory-II, M male, F female, new/rec newly diagnosed/recurrent tumor, F frontal, T temporal, P parietal, O occipital, R right, L left, M midline, lat lateral